Darren SissonsWright Medical Group IncWMGIBUYJul 25, 2014

(Top Pick Apr 24/14, Down 11.62%) He bought before there was an indiscretion between the CEO and one of his officers. They acquired a competitor and then he sold out and made a nice profit.

(A Top Pick May 2/14. Down 13.72%.) Had liked its business and liked it because it was a turnaround stock. The new CEO had a good history of turning companies around and then selling them. Instead of turning this one around, he made an acquisition. He wasn’t happy with this, so sold his holdings.

Owned it because the CEO had a history of turning companies around. Until last week they were doing a good job of that until they decided to do an acquisition rather than being sold, so he sold it. Not sure how long the CEO will stick on.

Body parts. A turnaround situation. They are a leader in their area. There is an FDA decision coming down soon on an appeal to one of their products being rejected, but he does not think it is significant. If you are working with a health plan then you are more likely to get elective surgery done.

Was a turnaround story. Regulatory overhang, costs. That is all behind us. The CEO could be getting ready to leave, apparently and they thought someone would snap up this company. Still thinks there is some upside.

(A Top Pick July 31/13. Up 12%.) This company is in prosthetics, specializing in extremities such as toes, fingers, wrists, etc. If you have health insurance, you are more likely to get work that needs done than if you don’t have it. Has been held back compared to some competitors because there have been takeovers of competitors. Would still be a buyer. $36 in 12 months would be a reasonable estimate.

A body parts company: fingers, toes, angles and other extremities. He bought it on the turn-around and it would be a bonus if they sold the company. Likes the growth they are generating internally.

Hospital supplies. Tends to be a little more volatile because it is a turnaround story. Also, doesn’t have a dividend. If you don’t like volatility, consider Covidian (COV-N) which is a better alternative. He believes ultimately this will be taken out because the CEO has a track record of going in, fixing up and selling companies.

Body parts company. Extremities, especially the foot area. Earnings and sales are growing nicely. Are the biggest in the ankle business and are a potential target for an acquirer. Sold off recently because of an acquisition they made. Earnings are growing very, very nicely in the meantime.

A pure play on fingers, toes, and ankles. Thinks there is still some upside.

Used to be in hips and knees replacements which was a very commodity oriented competitive business. Sold those businesses and is now a specialty provider of extremities such as fingers, toes, ankles, wrists, etc. Had some problems a few years ago and brought in a CEO who was a turnaround artist who turns companies around, makes them profitable and then sells them. Believes that this is what is happening here.

(A Top Pick July 27/12. Up 46.15%.) Manufactures replacement body parts. This company is a small player and has been pretty broad in its product offering. Its specialty has been in extremities such as fingers, toes, ankles, wrists, etc. They are in the process of selling their other areas such as knees, hips, etc. The extremities is a high growth business. CEO has a history of turning companies around and then selling them. Thinks he is in the process of doing this again.

Big growth is coming from extremities – fingers and toes. Baby boomers are getting new toes, fingers and hips. It is also a turn-around story. In ’09 there was some regulatory misconduct.